Lipoedema and Bariatric and Metabolic Surgery: A Systematic Review.

Clinical obesity 2026 Vol.16(1) p. e70062

Pajaziti Q, Geropoulos G, MacVicar E, Colucci N, Lucocq J, Lamb PJ, Robertson AG

관련 도메인

Abstract

Lipoedema is a chronic, progressive condition characterised by disproportionate fat accumulation in the lower extremities, often misdiagnosed due to symptom overlap with obesity. Weight management is a key component of lipoedema treatment, yet the role of bariatric surgery remains unclear. This systematic review evaluates the impact of bariatric and metabolic surgery (BMS) on lipoedema symptoms, weight loss outcomes, and the need for further interventions. A systematic search of PubMed, Scopus and the Cochrane Library was conducted up to January 2025 following PRISMA guidelines. Studies reporting on patients with lipoedema (or equivalent diagnoses) who underwent BMS were included. Quality was assessed using the Joanna Briggs Institute (JBI) checklist for case reports and the National Heart, Lung and Blood Institute (NHLBI) tool for case series. Seven studies met the inclusion criteria (five case reports, two cohort studies), comprising 51 patients. All underwent BMS, primarily sleeve gastrectomy or Roux-en-Y gastric bypass. One study (n = 31) reported a significant reduction in thigh volume and weight loss comparable to controls. The remaining studies found persistent or worsened lower body disproportionality and no improvement in pain. Postoperative lipoedema diagnoses were common, raising concerns over diagnostic accuracy. Overall weight loss averaged 33.9% total weight loss. Bariatric and metabolic surgery achieves meaningful weight reduction in patients with lipoedema and obesity but does not consistently improve core lipoedema symptoms. Its role remains adjunctive rather than primary. Preoperative identification and documentation of lipoedema features are recommended, with a postoperative plan for adjunct conservative therapies and selective consideration of lymph-sparing liposuction where symptoms persist. Larger prospective studies using standardised definitions and outcome measures are needed to clarify its therapeutic value in this population.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 liposuction 지방흡입 dict 1
해부 fat scispacy 1
해부 Heart scispacy 1
해부 Lung scispacy 1
해부 Blood scispacy 1
해부 gastric scispacy 1
해부 thigh scispacy 1
합병증 extremities scispacy 1
합병증 lipoedema scispacy 1
질환 Lipoedema C0398370
Lipedema
scispacy 1
질환 obesity C0028754
Obesity
scispacy 1
질환 weight loss C1262477
Weight Loss
scispacy 1
질환 pain C0030193
Pain
scispacy 1
질환 Postoperative lipoedema scispacy 1
질환 weight reduction C1262477
Weight Loss
scispacy 1
기타 patients scispacy 1

MeSH Terms

Humans; Bariatric Surgery; Lipedema; Weight Loss; Obesity, Morbid; Treatment Outcome; Female

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문